Ronald M. Kurtz M.D., President & CEO at RxSight, Inc. (RXST), sold 40,000 shares at $60.15 ($2.4M) on 2024-05-03, disclosed to the SEC on 2024-05-06.
Scheduled sale ($2.4M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RXST | SELL | 2023-12-29 | $1.8M | — | Filing → |
| RXST | SELL | 2023-12-18 | $1.6M | — | Filing → |
| RXST | BUY | 2021-08-05 | $2.1M | — | Filing → |